Biktarvy, formally known as bictegravir, is a effective single-tablet therapy for treating HIV infection. This drug combines three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the HIV's ability to replicate within the body, considerably decreasing the viral load. For many individual